Publications
88
Citations
1,715
Est. group size
~5
Recurring co-author estimate
Active years
28
Publishing since 1999
Jieli Li works in clinical laboratory medicine and pathology, focusing on evaluating and improving diagnostic tests used in hospitals, such as hormone assays, cardiac biomarker tests, and immunoassays. Much of the work involves comparing testing platforms (e.g., from Siemens, Roche, Beckman) for accuracy, and exploring how new tools like machine learning and language models might assist in interpreting lab results. This research is aimed at improving the reliability and quality of clinical diagnostic testing used in patient care.
Publication output has been relatively steady over the last decade, with some year-to-year fluctuation but a generally consistent or slightly increasing pace in recent years (around 7-9 papers per year since 2022).
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Evaluation of the Siemens Healthineers Atellica TSTII testosterone assay in the CDC HoSt-TT program
The Journal of Clinical Endocrinology & Metabolism · 2026
- Machine learning in pathology and clinical laboratory medicine: a narrative review
Journal of Laboratory and Precision Medicine · 2026
- Advancing patient safety through laboratory quality indicators in clinical pathology
Critical Reviews in Clinical Laboratory Sciences · 2026
- Performance evaluation of large language models with chain-of-thought reasoning ability in clinical laboratory case interpretation
Clinical Chemistry and Laboratory Medicine (CCLM) · 2025
- Prevalence and Clinical Impact of Pseudohypercalcemia in Paraproteinemia: A Case and Cohort Study
Journal of Clinical Medicine · 2025
- R&D Internationalization: A Review and Future Agendas
SSRN Electronic Journal · 2025
- R&D Internationalization Portfolio, Absorptive Capacities and Innovation Performance: Based on Configurational Approach
SSRN Electronic Journal · 2025
- B-364 Changing Immunochemistry Platforms: Analytical and Clinical analysis of cancer antigen (CA) 15-3 and 27.29 testing
Clinical Chemistry · 2025
- A-371 Analytical Comparison of Point-of-Care and Laboratory-Based High-Sensitivity Troponin I Assays
Clinical Chemistry · 2025
- 422 Evaluation of Lipemia Interference in Immunoassays Using Native Patient Samples and Ultracentrifugation
American Journal of Clinical Pathology · 2025
- 144 Analytical Performance Evaluation of the Erythropoietin Assay on the Siemens Atellica IM Analyzer
American Journal of Clinical Pathology · 2025
- Challenges of insulin-like growth factor-1 testing
Critical Reviews in Clinical Laboratory Sciences · 2024
- Evaluation of Siemens Atellica AMH assay and comparison with Roche, Beckman and Ansh Labs
Clinical Biochemistry · 2024
- Insights into insulin analog cross-reactivity: a comparative study of Siemens Atellica and LC-MS/MS
Endocrine · 2024
- Evaluation of Age and Sex Differences in Contemporary versus High-Sensitivity Troponin I Measurement in Hospitalized Patients
Journal of Clinical Medicine · 2024
- Clinical Chemistry×4
- American Journal of Clinical Pathology×4
- Figshare×4
- Endocrine×3
- Clinica Chimica Acta×3
- Pei-En Chou
Medicine · Purdue University West Lafayette
- Sarah M. Heissler
Medicine · The Ohio State University
- Taeyoon Kim
Medicine · Purdue University West Lafayette
- Hsiang-Ling Huang
Medicine · The Ohio State University
- Jason Cowan
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile